Page last updated: 2024-09-05

sb 203580 and 4-hydroxy-2-hexenal

sb 203580 has been researched along with 4-hydroxy-2-hexenal in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(4-hydroxy-2-hexenal)
Trials
(4-hydroxy-2-hexenal)
Recent Studies (post-2010) (4-hydroxy-2-hexenal)
3,48941,137102149

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, HY; Go, EK; Je, JH; Jung, KJ; Lee, JY; Sung, B; Yu, BP1

Other Studies

1 other study(ies) available for sb 203580 and 4-hydroxy-2-hexenal

ArticleYear
NF-kappaB activation mechanism of 4-hydroxyhexenal via NIK/IKK and p38 MAPK pathway.
    FEBS letters, 2004, May-21, Volume: 566, Issue:1-3

    Topics: Aldehydes; Animals; Biological Transport; DNA-Binding Proteins; Endothelial Cells; Enzyme Inhibitors; Flavonoids; I-kappa B Kinase; Imidazoles; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; NF-kappa B; NF-kappaB-Inducing Kinase; p38 Mitogen-Activated Protein Kinases; Peroxynitrous Acid; Prostate; Protein Serine-Threonine Kinases; Pyridines; Rats; Transcription Factor RelA; Transfection

2004